A Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS

Importance of Topic

Understanding drugs of abuse in blood is critical in clinical and forensic investigations. Rapid qualitative screening in blood complements urine analysis and provides reliable court-admissible evidence. The complexity of blood matrices and wide range of target compounds necessitate streamlined methods that minimize sample preparation and maximize throughput.

Objectives and Study Overview

This study aimed to develop and validate a fast, low-cost GC/MS approach for detecting a broad panel of drugs of abuse directly in whole blood using a Thermal Separation Probe (TSP) coupled to an Agilent 5975T low thermal mass (LTM) GC/MS system. Key goals included eliminating cleanup steps, shortening analysis time, and ensuring sensitivity for multiple drug classes.

Methodology and Instrumentation

Instrument Configuration:

• Agilent 5975T LTM GC/MS with split/splitless inlet and TSP microvial introduction
• Agilent HP-5ms LTM column (10 m × 0.18 mm, 0.18 μm) with a 1 m guard column
• Split injection (10:1), 1 μL volume, inlet at 280 °C
• Temperature program: 12 s hold at 90 °C, ramp to 320 °C at 60 °C/min, hold 2.75 min
• Carrier gas: Helium, transfer line 280 °C, ion source 230 °C, quadrupole 150 °C
• Full scan MS (m/z 30–500), EMV gain factor 5.00

Sample Preparation:
Whole blood samples (3–5 μL) were spotted onto dehydrated Na₂SO₄ in the TSP vial. No further cleanup was performed. Standards (0.1–40 ng/μL) were prepared by spiking blood.
Software:
Agilent Deconvolution Reporting Software (DRS) integrated with ChemStation and NIST AMDIS/NIST08 libraries for peak deconvolution and library matching.

Main Results and Discussion

The translated fast method reduced run times to 6.5 minutes without significant loss of resolution. Out of 63 target drugs, 56 thermally stable compounds were analyzed; over 94 % achieved a method detection limit of 5 ng/μL. Deconvolution enabled reliable identification even within complex blood matrices, as demonstrated for chlorpromazine and other analytes. Some labile drugs exhibited decomposition and required higher concentrations for detection.

Benefits and Practical Applications

• Eliminates time-consuming and costly sample cleanup
• Portable setup suitable for remote or on-site forensic screening
• High throughput with short GC cycles (~6.5 min)
• Reduced human error and consistent retention times via LTM GC technology
• Court-admissible qualitative evidence through GC/MS spectral identification

Future Trends and Potential Applications

Further expansion of target analyte lists and automation of TSP handling could enhance screening breadth. Integration with portable data analysis platforms and miniaturized GC/MS instruments may enable real-time field deployments for emergency and forensic response.

Conclusion

The combination of a Thermal Separation Probe and low thermal mass GC/MS provides a rapid, robust, and cleanup-free method for detecting drugs of abuse in whole blood. The approach achieves high sensitivity and throughput, making it valuable for forensic and clinical laboratories seeking efficient qualitative screening.